| Name | BMS813160 |
|---|---|
| Synonyms | BMS-813160 |
| Description | BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular. |
|---|---|
| Related Catalog | |
| Target |
CCR2 CCR5 |
| References |
| Molecular Formula | C25H40N8O2 |
|---|---|
| Molecular Weight | 484.64 |
| Storage condition | 2-8℃ |